Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An epidemiOlogy Study to deteRmine the Prevalence of EGFR muTations in RUSsian Patients With Advanced NSCLC (ORTUS)

NCT02321046 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02321046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02321046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An epidemiOlogy Study to deteRmine the Prevalence of EGFR muTations in RUSsian Patients With Advanced NSCLC (ORTUS)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 2, 2015
Completion date
June 28, 2019
Enrollment
26 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer